Allan S. Brett
Abstract
The uricosuric agent probenecid is indicated in gout patients who require urate-lowering therapy, underexcrete uric acid, and are intolerant of allopurinol. In this retrospective study from a rheumatology clinic in New Zealand, researchers describe their experience with this drug. Of 521 gout patients in this clinic, …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The uricosuric agent probenecid is indicated in gout patients who require urate-lowering therapy, underexcrete uric acid, and are intolerant of allopurinol. In this retrospective study from a rheumatology clinic in New Zealand, researchers describe their experience with this drug. Of 521 gout patients in this clinic, …
Key concepts: Probenecid, Gout, Medicine, Allopurinol, Uricosuric, Febuxostat, Sulfinpyrazone, Benzbromarone